Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

545 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pregnancy in heart- and heart/lung recipients can be problematic.
Estensen M, Gude E, Ekmehag B, Lommi J, Bjortuft O, Mortensen S, Nystrom UM, Simonsen S. Estensen M, et al. Among authors: mortensen s. Scand Cardiovasc J. 2011 Dec;45(6):349-53. doi: 10.3109/14017431.2011.605168. Epub 2011 Aug 31. Scand Cardiovasc J. 2011. PMID: 21879798
Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate.
Arora S, Gude E, Sigurdardottir V, Mortensen SA, Eiskjær H, Riise G, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Aukrust P, Solbu D, Iversen M, Gullestad L. Arora S, et al. Among authors: mortensen sa. J Heart Lung Transplant. 2012 Mar;31(3):259-65. doi: 10.1016/j.healun.2011.12.010. J Heart Lung Transplant. 2012. PMID: 22333403 Clinical Trial.
Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
Gullestad L, Iversen M, Mortensen SA, Eiskjaer H, Riise GC, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Gude E, Rundqvist B, Fagertun HE, Solbu D, Bergh CH. Gullestad L, et al. Among authors: mortensen sa. Transplantation. 2010 Apr 15;89(7):864-72. doi: 10.1097/TP.0b013e3181cbac2d. Transplantation. 2010. PMID: 20061999 Clinical Trial.
Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial.
Gullestad L, Mortensen SA, Eiskjær H, Riise GC, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Gude E, Rundqvist B, Fagertun HE, Solbu D, Iversen M. Gullestad L, et al. Among authors: mortensen sa. Transplantation. 2010 Dec 27;90(12):1581-9. doi: 10.1097/TP.0b013e3181fd01b7. Transplantation. 2010. PMID: 21030905 Clinical Trial.
Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial.
Arora S, Ueland T, Wennerblom B, Sigurdadottir V, Eiskjær H, Bøtker HE, Ekmehag B, Jansson K, Mortensen SA, Saunamaki K, Simonsen S, Gude E, Bendz B, Solbu D, Aukrust P, Gullestad L. Arora S, et al. Among authors: mortensen sa. Transplantation. 2011 Jul 27;92(2):235-43. doi: 10.1097/TP.0b013e31822057f1. Transplantation. 2011. PMID: 21677600 Clinical Trial.
545 results